logo-loader
viewMicrosoft Corporation

Microsoft boosted by approval of new $40 billion stock buyback program, 11% dividend hike

It is the third time the software giant’s board has authorized a buyback plan of that size, having previously done so in 2013 and again in 2016

Microsoft logo
Microsoft also raised its quarterly dividend by 5 cents to 51 cents a share

Microsoft Corp. (NASDAQ:MSFT) shares bounded higher on Thursday, looking on track to close at a new record high, boosted by the approval of a new $40 billion stock buyback program and news of an 11% quarterly dividend.

It is the third time the software giant’s board has authorized a buyback plan of that size, having previously done so in 2013 and again in 2016 – with the firm due to reach the end of the 2016 share-buyback program within the next few months.

READ: Microsoft flies above $1trn high as cloud lifts earnings

Microsoft also raised its quarterly dividend by 5 cents to 51 cents a share, a slightly higher increase than the company announced a year ago

The dividend hike puts the software stock's implied yield at 1.47%, above Apple Inc.'s (NASDAQ:AAPL) at 1.38%.

Microsoft stock, which is up 40% so far this year, hit a new intraday peak of $142.37 in morning trade on Thursday, above its previous record close of $141.32 hit on July 26, before easing back to $141.57.

The group is currently the world’s biggest publicly-traded company, with a market cap of $1.06 trillion based on Wednesday’s closing share price, just above Apple’s at $1.01 trillion.

Contact the author at [email protected]

Quick facts: Microsoft Corporation

Price: 136.25 USD

NASDAQ:MSFT
Market: NASDAQ
Market Cap: $1.05 trillion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Merck Head of Pacific BD&L sees a 'coming of age' in how the immune system...

Merck & Co (NYSE:MRK) Head of Pacific Business Development & Licensing Hub and President of the MRL Ventures Fund Reza Halse sat down with Proactive at the BIO Investor Forum in San Francisco.  Halse says he's seeing a 'coming of age' in neuroscience, especially seeing an...

2 hours, 27 minutes ago

2 min read